ClinicalTrials.gg
RecruitingNCT07649733BENESTARUpdated Jun 16, 2026

Projecte Benestar 2026: Virtual Reality Program for Healthcare Workers

An interventional study of Projecte Benestar Virtual Reality Educational Program in Burnout, Healthcare Workers, Occupational Stress and Mental Health Issue, sponsored by Badalona Serveis Assistencials. Recruiting at 2 sites in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Badalona Serveis Assistencials · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Burnout, Psychological with a site in Spain — 5 open to participants now, 7 under way, none of them phase 3. Burnout, Psychological · Spain.

Planned enrollment
11th of 16
100 · median 130
Started
2026
with 5 others
No phase
15 of 18
4 open now
Registered
14th of 18
by date
Lead sponsor
1 of 18
Badalona Serveis Assistencials

Among the 18 studies in Burnout, Psychological with a site in Spain, this one is the 11th largest by planned enrollment of the 16 interventional ones that give a count, is one of 6 that started in 2026, is one of 15 with no phase, and was the 14th registered.

Burnout, Psychological

468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

Browse Burnout, Psychological studies →

Open to participants now

5 of the 18 studies in Burnout, Psychological with a site in Spain are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 65 Burnout, Psychological studies recruiting now, 43 (66%) set no upper age limit and 16 (25%) stop at 75 or younger; 14 take children under 18; 33 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Burnout, Psychological with a site in Spain, or all of them as a file.
02

Study summary

Projecte Benestar 2026 is a multicenter randomized controlled study evaluating a brief immersive educational program delivered through virtual reality for healthcare workers. The program is designed to support emotional well-being, self-care, mindfulness, and emotional regulation in professionals working in healthcare settings.

Participants will be active healthcare or healthcare-support workers from participating centers. They will be randomly assigned to one of two groups. One group will receive the virtual reality program at the beginning of the study, while the other group will continue usual activity and receive the same program later, after a wait-list period.

The main objective is to evaluate whether the program reduces emotional exhaustion, measured with the Maslach Burnout Inventory. Secondary objectives include evaluating changes in depersonalization, personal accomplishment, work engagement, usability, satisfaction, adherence, and tolerability of the virtual reality program.

Read the detailed description

This is a multicenter randomized controlled trial with a delayed-start wait-list control design. The study will evaluate Projecte Benestar, an immersive educational virtual reality program designed to support emotional well-being, self-care, mindfulness, emotional regulation, and self-compassion among workers in healthcare settings.

The study population will include active professionals working in participating healthcare organizations, including clinical and non-clinical staff with direct healthcare contact or support functions. Participating institutions may include primary care, hospital, and intermediate care settings. Recruitment will be conducted among eligible workers who voluntarily agree to participate and provide informed consent.

Participants will be randomized in a 1:1 ratio, stratified by center, to one of two study groups. Group A will receive the intervention during the first weeks of the study. Group B will continue usual activity during the initial period and will receive the same intervention after a wait-list period of approximately 6 months. This delayed-start design allows comparison between immediate intervention and usual activity while ensuring that all participants are eventually offered the program.

The intervention consists of eight brief individual virtual reality sessions delivered through autonomous virtual reality headsets. Each session lasts approximately 9 to 15 minutes and combines short educational content with guided immersive practice. The contents include mindfulness, breathing exercises, body scan practices, emotional regulation strategies, the RAIN technique, self-compassion, and a final integration session. Sessions may be delivered in a standard 8-week format with one session per week, or in an intensive 4-week format with two sessions per week, depending on local logistical capacity.

The virtual reality content is fixed and non-adaptive. All participants receive the same sequence of sessions. The application does not require internet connection during use and does not collect automatic data from the device. Participants complete sessions seated in a quiet institutional space, with a local study reference person available for technical support or in case of discomfort.

The primary outcome is change in emotional exhaustion measured with the Maslach Burnout Inventory-Human Services Survey. Secondary outcomes include the other burnout dimensions of depersonalization and personal accomplishment, work engagement measured with the Utrecht Work Engagement Scale, usability measured with the System Usability Scale, participant satisfaction, adherence to the sessions, and tolerability or incidents related to virtual reality use.

Data will be collected at baseline, after the first intervention cycle, at 6 months, after the delayed intervention cycle, and at 12 months. The main analysis will compare changes in outcomes between the immediate intervention group and the wait-list control group, with additional within-group pre-post analyses and follow-up assessments over time.

03

Conditions studied

  • Burnout, Healthcare Workers
  • Occupational Stress
  • Mental Health Issue

Keywords

  • Virtual Reality
  • Mindfulness
  • Healthcare workers
  • Burnout
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Active permanent or temporary staff member at a participating healthcare center where the program is implemented
  • Age 18 years or older
  • Able to understand, accept, and sign the form
  • Willing to complete the study procedures, attend the planned weekly sessions, and complete the study questionnaires

Exclusion criteria

Exclusion Criteria:

  • Photosensitive epilepsy or history of seizures triggered by visual stimuli
  • Severe motion sickness or previous intolerance to immersive devices
  • Visual or hearing impairment that prevents adequate use of the virtual reality headset
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Immediate Intervention: Projecte Benestar VR Program

    Participants randomized to this arm will receive the Projecte Benestar virtual reality educational program during the first intervention period. The program includes 8 individual immersive sessions focused on mindfulness, breathing, body scan, emotional regulation, RAIN, self-compassion, and integration. Sessions last approximately 9 to 15 minutes and may be delivered over 8 weeks or 4 weeks depending on center logistics.

    Behavioral: Projecte Benestar Virtual Reality Educational Program

  • Other
    Wait-list Control: Delayed Projecte Benestar VR Program

    Participants randomized to this arm will continue usual activity during the initial wait-list control period. After approximately 6 months, they will receive the same Projecte Benestar virtual reality educational program, consisting of 8 individual immersive sessions focused on mindfulness, breathing, body scan, emotional regulation, RAIN, self-compassion, and integration.

    Behavioral: Projecte Benestar Virtual Reality Educational Program

Interventions

  • BehavioralProjecte Benestar Virtual Reality Educational Program

    Projecte Benestar is an immersive educational virtual reality program focused on mindfulness, emotional regulation, and self-compassion for workers in healthcare settings. The program includes 8 individual sessions delivered through autonomous virtual reality headsets. Each session lasts approximately 9 to 15 minutes and includes guided audio and immersive 3D content. Sessions may be delivered over 8 weeks or in an intensive 4-week format, depending on local logistics.

06

What researchers measure

Primary outcomes

  1. Change in Emotional Exhaustion Score on the Maslach Burnout Inventory-Human Services Survey

    Emotional exhaustion will be assessed using the Emotional Exhaustion subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 9 items scored from 0 to 6, with total scores ranging from 0 to 54. Higher scores indicate greater emotional exhaustion. Changes will be compared between the immediate intervention group and the wait-list control group during the first intervention period, and will also be assessed after the delayed intervention group completes the program.

    Time frame: Baseline, approximately 4 to 8 weeks, and approximately 7 months

Secondary outcomes

  1. Change in Depersonalization Score on the Maslach Burnout Inventory-Human Services Survey

    Depersonalization will be assessed using the Depersonalization subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 5 items scored from 0 to 6, with total scores ranging from 0 to 30. Higher scores indicate greater depersonalization.

    Time frame: Baseline, approximately 4 to 8 weeks, and approximately 7 months

  2. Change in Personal Accomplishment Score on the Maslach Burnout Inventory-Human Services Survey

    Personal accomplishment will be assessed using the Personal Accomplishment subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 8 items scored from 0 to 6, with total scores ranging from 0 to 48. Higher scores indicate greater personal accomplishment.

    Time frame: Baseline, approximately 4 to 8 weeks, and approximately 7 months

  3. Change in Vigor Score on the Utrecht Work Engagement Scale-9

    Vigor will be assessed using the Vigor dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater vigor, reflecting higher energy and mental resilience at work.

    Time frame: Baseline, approximately 4 to 8 weeks, and approximately 7 months

  4. Change in Dedication Score on the Utrecht Work Engagement Scale-9

    Dedication will be assessed using the Dedication dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater dedication, reflecting a stronger sense of significance, enthusiasm, inspiration, pride, and challenge at work.

    Time frame: Baseline, approximately 4 to 8 weeks, and approximately 7 months

  5. Change in Absorption Score on the Utrecht Work Engagement Scale-9

    Absorption will be assessed using the Absorption dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater absorption, reflecting being more fully concentrated and deeply involved in work.

    Time frame: Baseline, approximately 4 to 8 weeks, and approximately 7 months

  6. System Usability Scale Score After the Virtual Reality Program

    Usability will be assessed using the System Usability Scale, a 10-item questionnaire that provides a global usability score ranging from 0 to 100. Higher scores indicate greater perceived usability of the virtual reality program.

    Time frame: After completion of the intervention: approximately 4 to 8 weeks for the immediate intervention group and approximately 7 months for the delayed intervention group

  7. Participant Satisfaction With the Virtual Reality Program

    Satisfaction will be assessed using 2 ad hoc visual analog scale items scored from 0 to 10. The items assess perceived usefulness of the intervention and willingness to recommend the experience to colleagues. Higher scores indicate greater satisfaction.

    Time frame: After completion of the intervention: approximately 4 to 8 weeks for the immediate intervention group and approximately 7 months for the delayed intervention group

  8. Adherence to the Virtual Reality Program

    Adherence will be calculated as the percentage of completed virtual reality sessions out of the total planned sessions. The program includes 8 planned sessions. Higher percentages indicate greater adherence to the intervention.

    Time frame: From intervention start to intervention completion, approximately 4 to 8 weeks

Other outcomes

  1. Tolerability of the Virtual Reality Program

    Tolerability will be assessed immediately after Sessions 1 through 8 and at intervention completion by recording symptoms related to virtual reality use, including eye fatigue, blurred vision, headache, dizziness, nausea, disorientation, anxiety, or ergonomic discomfort. Symptoms will be rated using an ad hoc 4-point scale from none to severe. Lower scores indicate better tolerability.

    Time frame: Immediately after Sessions 1 through 8 and at intervention completion, up to 8 weeks

  2. Incidence of Virtual Reality-Related Adverse Events or Session Interruptions

    Virtual reality-related incidents will be recorded after each session using a session incident log. Events may include dizziness, cybersickness, headache, anxiety, visual discomfort, or other symptoms leading to session interruption or withdrawal. The outcome will be summarized as the number and proportion of participants with any recorded incident.

    Time frame: From intervention start to intervention completion, approximately 4 to 8 weeks

07

Study locations

2 of 2 sites recruiting
  • Badalona Serveis Assistencials
    Badalona, Barcelona 08911, Spain
    Recruiting
  • ABS Valls Urbà | Gerència d'Atenció Primària i a la Comunitat
    Valls, Tarragona 43800, Spain
    Recruiting
08

References and documents

Publications

  • Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory Manual. 4th ed. Mind Garden; 2018.
  • Dominguez-Salas S, Rodriguez-Dominguez C, Arcos-Romero AI, Allande-Cusso R, Garcia-Iglesias JJ, Gomez-Salgado J. Psychometric Properties of the Utrecht Work Engagement Scale (UWES-9) in a Sample of Active Health Care Professionals in Spain. Psychol Res Behav Manag. 2022 Nov 30;15:3461-3472. doi: 10.2147/PRBM.S387242. eCollection 2022. PubMed 36474956 ↗
  • Ferrer Costa J, Moran N, Garcia Marti C, Colmenares Hernandez LJ, Radu Ciorba Ciorba F, Ciudad MJ. Immediate Impact of an 8-Week Virtual Reality Educational Program on Burnout and Work Engagement Among Health Care Professionals: Pre-Post Pilot Study. JMIR XR Spat Comput. 2024 Apr 25;1:e55678. doi: 10.2196/55678. eCollection 2024. PubMed 41341876 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in future publications may be shared upon reasonable request to the corresponding author. Data will not be publicly available in an open repository. Access will be subject to approval by the study investigators, institutional data protection requirements, and, where required, a data sharing agreement.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: De-identified individual participant data and supporting documents will be available beginning 6 months after publication of the main study results and for 5 years thereafter.

Access criteria: De-identified individual participant data underlying the published results may be shared upon reasonable request to the corresponding author. Access will be limited to researchers who provide a methodologically sound proposal for approved research purposes. Requests will be reviewed by the study investigators and, where required, by the participating institutions. Data will not be made publicly available in an open repository. Access will be subject to applicable data protection requirements and, if required, a data sharing agreement.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2027, 18 months after the start.

Of 253 non-industry interventional studies with no phase under Burnout, Psychological, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 18 months is above that.

Counting every sponsor, half of 260 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2026
First posted
Jun 16, 2026
StartActual
Jun 8, 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Jun 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07649733
Lead sponsor
Badalona Serveis Assistencials
Collaborators
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Corporació de Salut del Maresme i la Selva, Institut Catala de Salut
Responsible party
Jose Ferrer Costa (Family Physician, Coordinating Investigator, Badalona Serveis Assistencials) — Principal investigator
First posted
Jun 16, 2026
Start date
Jun 8, 2026
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jun 16, 2026

Study contacts

José Ferrer Costa, MD, MSc
Contact
jfcosta@bsa.cat
+34937407482
Rosa García Sierra, RN, PhD, MSc
Contact
rgarciasi.mn.ics@gencat.cat
+3493 741 53 38
Jose Ferrer Costa, MD, MSc
principal investigator · Badalona Serveis Assistencials - Universitat Oberta de Catalunya

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion